Bifogade filer
PDF
Hørsholm, Denmark, 20 January 2026 - ExpreS2ion Biotech Holding AB's today announces that, effective today, 20 January 2026, the Company will transition its press release distribution from Cision to MFN (Modular Finance News). Subscribers who wish to continue receiving the Company's press releases must register on the MFN platform. This change is part of the Company's ongoing efforts to streamline regulatory news distribution.
To continue receiving Expres2ion Biotech Holding's press releases, including future regulatory announcements, current subscribers of Cision News are required to register on the MFN platform.
How to subscribe via MFN
Subscribers can sign up to receive future press releases and updates here:
https://mfn.se/all/a/expres2ion-biotech-holding
Once registered, subscribers will receive press releases and other Company announcements directly through MFN's distribution channels.
About the Change
The Company has selected MFN as its official distribution service for press releases and regulatory announcements, providing reliable and compliant dissemination to the market.
Certified Adviser
Svensk Kapitalmarknadsgranskning AB